FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation today announced it has received clearance from the Food and Drug Administration of its latest innovation in guiding catheters: the ADROIT TM 6F ...

Cordis is recalling the Super Torque MB angiographic catheter with radiopaque marker bands, the US Food and Drug Administration announced this week, categorizing the action as a class I recall, the ...

Cordis Corp., Johnson & Johnson's stenting arm, notched another 510(k) clearance for its Adroit 6F Guiding Catheter, which the company says can handle more sophisticated lesions. Cordis Corp., the ...

SAN FRANCISCO--(BUSINESS WIRE)--Cordis Corporation today announced EMPIRA™ and EMPIRA™ NC RX PTCA Dilatation Catheters have received 510(k) regulatory clearance for the treatment of coronary artery ...

The FDA determined this week that Cordis’ recent recall of several versions of its Super Torque angiographic catheters meet the criteria of a Class I recall, a label reserved for those the agency ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014” Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter designed to ...

January 25, 2008 (Miami Lakes, FL) - Cordis is recalling certain lots of its recently introduced Fire Star RX and Dura Star RX coronary balloon catheters because they pose a risk of "slow deflation or ...

Medical devices group Clearstream Technologies has signed a landmark deal with US health care giant Johnson & Johnson. The Arklow-based manufacturer of cardiac intervention devices has agreed to ...

After six years, Cardinal Health is dropping its Cordis medical device division, makers of cardiovascular catheters and diagnostic hardware, in a $1 billion deal with private equity firm Hellman & ...